Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kanaoka, Daiki
40  Ergebnisse:
Personensuche X
?
1

FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultan..:

Kanaoka, Daiki ; Yamada, Mitsuo ; Yokoyama, Hironori...
Cancer Research Communications.  4 (2024)  2 - p. 312-327 , 2024
Link: https://doi.org/10.1158/..
 
?
2

Origami Tessellations Induced by Growth:

, In: Proceedings of the SIGGRAPH Asia 2022 Art Gallery,
Tachi, Tomohiro ; Horikawa, Junichiro ; Kanaoka, Daiki - p. 1 ff. , 2022
Link: https://dl.acm.org/doi/1..
 
?
3

P70 Involvement of endogenous hydrogen sulfide and T-type c..:

Sekiguchi, Fumiko ; Takeda, Yuki ; Kanaoka, Daiki..
Nitric Oxide.  39 (2014)  - p. S37 , 2014
Link: https://doi.org/10.1016/..
 
?
4

Endogenous and exogenous hydrogen sulfide facilitates T-typ..:

Sekiguchi, Fumiko ; Miyamoto, Yosuke ; Kanaoka, Daiki...
Biochemical and Biophysical Research Communications.  445 (2014)  1 - p. 225-229 , 2014
Link: https://doi.org/10.1016/..
 
?
5

AKAP‐dependent sensitization ofCav3.2 channels via theEP4re..:

Sekiguchi, Fumiko ; Aoki, Yuka ; Nakagawa, Maiko...
British Journal of Pharmacology.  168 (2013)  3 - p. 734-745 , 2013
Link: https://doi.org/10.1111/..
 
?
6

AKAP-dependent sensitization of Cav3.2 channels via the EP4..:

Sekiguchi, Fumiko ; Aoki, Yuka ; Nakagawa, Maiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579291.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
7

FIGURE 5 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152500.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
8

TABLE 1 from FPFT-2216, a Novel Anti-lymphoma Compound, Ind..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152485.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Table S2 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152476.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
10

Figure S4 from FPFT-2216, a Novel Anti-lymphoma Compound, I..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152488.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Table S1 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152479.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Table S3 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152473.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Figure S2 from FPFT-2216, a Novel Anti-lymphoma Compound, I..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152494.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Table S3 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152473.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

FIGURE 2 from FPFT-2216, a Novel Anti-lymphoma Compound, In..:

Daiki Kanaoka ; Mitsuo Yamada ; Hironori Yokoyama...
doi:10.1158/2767-9764.25152509.v1.  , 2024
Link: https://doi.org/10.1158/..
 
1-15